Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1

Nucleic Acids Research

Volumn 30, Issue 18, 2002, Pages 4001-4008

  Chaloin, Laurent ^a   Lehmann, Maik Jörg ^b   Sczakiel, Georg ^c   Restle, Tobias ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; OLIGONUCLEOTIDE; RNA DIRECTED DNA POLYMERASE; TRANSFER RNA; VIRUS DNA; VIRUS ENZYME; VIRUS RNA;

ARTICLE; CELL LINE; CHIMERA; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID CELL; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; RNA BINDING; RNA SEQUENCE; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSMISSION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037106622     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkf522     Document Type: Article

References (50)

1. Robertson,D.L. and Joyce,G.F. (1990) Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature, 344, 467-468.
2. Tuerk,C. and Gold,L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science, 249, 505-510.
3. Ellington,A.D. and Szostak,J.W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature, 346, 818-822.
4. Brody,E.N. and Gold,L. (2000) Aptamers as therapeutic and diagnostic agents. J. Biotechnol., 74, 5-13.
5. Famulok,M., Mayer,G. and Blind,M. (2000) Nucleic acid aptamers-from selection in vitro to applications in vivo. Acc. Chem. Res., 33, 591-599.
6. James,W. (2001) Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery. Curr. Opin. Pharmacol., 1, 540-546.
7. White,R.R., Sullenger,B.A. and Rusconi,C.P. (2000) Developing aptamers into therapeutics. J. Clin. Invest., 106, 929-934.
8. Ruckman J., Green,L.S., Beeson J., Waugh,S., Gillette,W.L., Henninger,D.D., Claesson-Welsh,L. and Janjic,N. (1998) 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem., 273, 20556-20567.
9. Blind,M., Kolanus,W. and Famulok,M. (1999) Cytoplasmic RNA modulators of an inside-out signal-transduction cascade. Proc. Natl Acad. Sci. USA, 96, 3606-3610.
10. Shi,H., Hoffman,B.E. and Lis,J.T. (1999) RNA aptamers as effective protein antagonists in a multicellular organism. Proc. Natl Acad Sci. USA, 96, 10033-10038.
11. Mayer,G., Blind,M., Nagel,W., Bohm,T., Knorr,T., Jackson,C.L., Kolanus,W. and Famulok,M. (2001) Controlling small guanine-nucleotide-exchange factor function through cytoplasmic RNA intramers. Proc. Natl Acad. Sci. USA, 98, 4961-4965.
12. Famulok,M., Blind,M. and Mayer,G. (2001) Intramers as promising new tools in functional proteomics. Chem. Biol., 8, 931-939.
13. Richman,D.D. (2001) HIV chemotherapy. Nature, 410, 995-1001.
14. Symensma T.L., Giver,L., Zapp,M., Takle,G.B. and Ellington,A.D. (1996) RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo. J. Virol., 70, 179-187.
15. Yamamoto,R., Katahira,M., Nishikawa,S., Baba,T., Taira,K. and Kumar,P.K. (2000) A novel RNA motif that binds efficiently and specifically to the Ttat protein of HIV and inhibits the trans-activation by Tat of transcription in vitro and in vivo. Genes Cells, 5, 371-388.
16. Bahner,I., Kearns,K., Hao,Q.L., Smogorzewska,E.M. and Kohn,D.B. (1996) Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J. Virol., 70, 4352-4360.
17. Good,P.D., Krikos,A.J., Li,S.X., Bertrand,E., Lee,N.S., Giver,L., Ellington,A., Zaia,J.A., Rossi J.J. and Engelke,D.R. (1997) Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther., 4, 45-54.
18. Konopka,K., Duzgunes,N., Rossi,J. and Lee,N.S. (1998) Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs. J. Drug Target, 5, 247-259.
19. Düzgünes,N., Pretzer,E., Simoes,S., Slepushkin,V., Konopka,K., Flasher,D. and de Lima,M.C. (1999) Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells. Mol. Membr. Biol., 16, 111-118.
20. Konopka,K., Lee,N.S., Rossi,J. and Duzgunes,N. (2000) Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication. Gene, 255, 235-244.
21. Telesnitsky,A. and Goff,S.P. (1997) In Coffin,J.M., Hughes,S.H. and Varmus,H.E. (eds), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 121-160.
22. Tuerk,C., Macdougal,S. and Gold,L. (1992) RNA pseudoknots that inhibit human immunodeficiency virus type-1 reverse transcriptase. Proc. Natl Acad. Sci. USA, 89, 6988-6992.
23. Green,L., Waugh,S., Binkley,J.P., Hostomska,Z., Hostomsky,Z. and Tuerk,C. (1995) Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase. J. Mol. Biol., 247, 60-68.
24. Burke,D.H., Scates,L., Andrews,K. and Gold,L. (1996) Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase. J. Mol. Biol., 264, 650-666.
25. Jäger,J., Restle,T. and Steitz,T.A. (1998) The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor. EMBO J., 17, 4535-4542.
26. De Clercq,E. (2002) Strategies in the design of antiviral drugs. Nature Rev. Drug Discov., 1, 13-25.
27. Fisher,T.S., Joshi,P. and Prasad,V.R. (2002) Mutations that confer resistance to template-analog inhibitors of human immunodeficiency virus (HIV) type 1 reverse transcriptase lead to severe defects in HIV replication. J. Virol., 76, 4068-4072.
28. Kensch,O., Connolly,B.A., Steinhoff,H.J., McGregor,A., Goody,R.S. and Restle,T. (2000) HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding affinity in the low picomolar range coupled with high specificity. J Biol. Chem., 275, 18271-18278.
29. Thrall,S.H., Krebs,R., Wöhrl,B.W., Cellai,L., Goody,R.S. and Restle,T. (1998) Pre-steady-state kinetic characterization of RNA-primed initiation of transcription by HIV-1 reverse transcriptase and analysis of the transition to a processive DNA-primed polymerization mode. Biochemistry, 37, 13349-13358.
30. Krebs,R., Immendorfer,U., Thrall,S.H., Wöhrl,B.M. and Goody,R.S. (1997) Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC. Biochemistry, 36, 10292-10300.
31. Sambrook,J., Fritsch,E.F. and Maniatis,T. (1994) Molecular Cloning - A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
32. Rivas,E. and Eddy,S.R. (1999) A dynamic programming algorithm for RNA structure prediction including pseudoknots. J. Mol. Biol., 285, 2053-2068.
33. De Rijk,P. and De Wachter,R. (1997) RnaViz, a program for the visualisation of RNA secondary structure. Nucleic Acids Res., 25, 4679-4684.
34. Müller,B., Restle,T., Weiss,S., Gautel,M., Sczakiel,G. and Goody,R.S. (1989) Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli. J. Biol. Chem., 264, 13975-13978.
35. Müller,B., Restle,T., Kühnel,H. and Goody,R.S. (1991) Expression of the heterodimeric form of human immunodeficiency virus type 2 reverse transcriptase in Escherichia coli and characterization of the enzyme. J. Biol. Chem., 266, 14709-14713.
36. Restle T., Müller,B. and Goody,R.S. (1990) Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. J. Biol. Chem., 265, 8986-8988.
37. Jacques,P.S., Wöhrl,B.M., Ottmann,M., Darlix,J.L. and Le Grice,S.F. (1994) Mutating the 'primer grip' of p66 HIV-1 reverse transcriptase implicates tryptophan-229 in template-primer utilization. J. Biol. Chem., 269, 26472-26478.
38. Wigler,M., Pellicer,A., Silverstein,S., Axel,R., Urlaub,G. and Chasin,L. (1979) DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc. Natl Acad. Sci. USA, 76, 1373-1376.
39. Adachi,A., Gendelman,H.E., Koenig,S., Folks,T., Willey,R., Rabson,A. and Martin,M.A. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol., 59, 284-291.
40. Sczakiel,G. and Pawlita,M. (1991) Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J. Virol., 65, 468-472.
41. Hantzopoulos,P.A., Sullenger,B.A., Ungers,G. and Gilboa,E. (1989) Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl Acad. Sci. USA, 86, 3519-3523.
42. Adeniyi-Jones,S., Romeo,P.H. and Zasloff,M. (1984) Generation of long read-through,transcripts in vivo and in vitro by deletion of 3′ termination and processing sequences in the human tRNAimet gene. Nucleic Acids Res., 12, 1101-1115.
43. Sullenger,B.A., Gallardo,H.F., Ungers,G.E. and Gilboa,E. (1990) Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell, 63, 601-608.
44. Junker,U., Rittner,K., Homann,M., Bevec,D., Bohnlein,E. and Sczakiel,G. (1994) Reduction in replication of the human immunodeficiency virus type 1 in human T cell lines by polymerase III-driven transcription of chimeric tRNA-antisense RNA genes. Antisense Res. Dev., 4, 165-172.
45. Ilves,H., Barske,C., Junker,U., Bohnlein,E. and Veres,G. (1996) Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study. Gene, 171, 203-208.
46. Kuwabara T., Warashina,M., Koseki,S., Sano,M., Ohkawa,J., Nakayama,K. and Taira,K. (2001) Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3′ end can be exported efficiently and specifically to the cytoplasm in mammalian cells. Nucleic Acids Res., 29, 2780-2788.
47. Bertrand,E., Castanotto,D., Zhou,C., Carbonnelle,C., Lee,N.S., Good,P., Chatterjee,S., Grange,T., Pictet,R., Kohn,D. et al. (1997) The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA, 3, 75-88.
48. Yu,Q., Ottmann,M., Pechoux,C., Le Grice,S. and Darlix,J.L. (1998) Mutations in the primer grip of human immunodeficiency virus type 1 reverse transcriptase impair proviral DNA synthesis and virion maturation. J. Virol., 72, 7676-7680.
49. Mak,J., Jiang,M., Wainberg,M.A., Hammarskjold,M.L., Rekosh,D. and Kleiman,L. (1994) Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles. J. Virol., 68, 2065-2072.
50. Khorchid,A., Javanbakht,H., Wise,S., Halwani,R., Parniak,M.A., Wainberg,M.A. and Kleiman,L. (2000) Sequences within Pr160gag-pol affecting the selective packaging of primer tRNA(Lys3) into HIV-1. J. Mol. Biol., 299, 17-26.